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Sprouty, an Intracellular Inhibitor
of Ras Signaling
and Alberola-Ila, 1998). The signal is transduced in two
steps: first, of most relevance to this work, the tyrosine
phosphorylation of the cytoplasmic domains of recep-
Tanita Casci,² Javier VinoÂ s,² and Matthew Freeman*
MRC Laboratory of Molecular Biology
Hills Road
Cambridge CB2 2QH tors activates Ras1; second, Ras1 activates a cascade
of kinases, Raf, MEK, and MAP kinase. MAP kinaseUnited Kingdom
then enters the nucleus, where it phosphorylates target
transcription factors (Wassarman et al., 1995). How the
receptor triggers the activation of Ras1 is still unclear.Summary
At least three adaptor proteins, Drk, Dos, and Dab, bind
to the phosphorylated receptor and provide multipleSprouty was identified in a genetic screen as an inhibi-
binding sites for several downstream effectors (Oliviertor of Drosophila EGF receptor signaling. The Egfr trig-
et al., 1993; Simon et al., 1993; Herbst et al., 1996; Raabegers cell recruitment in the eye, and sprouty2 eyes
et al., 1996; Le and Simon, 1998). The best characterizedhave excess photoreceptors, cone cells, and pigment
of these is Sos (Simon et al., 1991), which activatescells. Sprouty's function is, however, more wide-
Ras by catalyzing the exchange of GDP for GTP. Thisspread. We show that it also interacts genetically with
activation is balanced by Gap1, which inhibits Ras bythe receptor tyrosine kinases Torso and Sevenless,
stimulating its intrinsic GTPase activity (Gaul et al.,and it was first discovered through its effect on FGF
1992). Importantly, Ras signaling occurs in complexesreceptor signaling. In contrast to an earlier proposal
associated with the inner face of the plasma membrane,that Sprouty is extracellular, we show by biochemical
and this localization is essential for the activity of manyanalysis that Sprouty is an intracellular protein, associ-
of the components of the pathway (Aronheim et al., 1994;ated with the inner surface of the plasma membrane.
Leevers et al., 1994; Stokoe et al., 1994).Sprouty binds to two intracellular components of the
Given the widespread importance of the Egfr in allRas pathway, Drk and Gap1. Our results indicate that
animals, we would like to understand the mechanismsSprouty is a widespread inhibitor of Ras pathway sig-
that control its activity and how these mechanisms arenal transduction.
integrated in development. We have therefore carried
out a genetic screen to identify new regulators of Egfr
signaling in Drosophila. One of the genes to emerge wasIntroduction
sprouty, a regulator of tracheal development in the fly
embryo (Hacohen et al., 1998). Tracheal branching isIntercellular signaling via the epidermal growth factor
controlled by the FGF receptor (Fgfr), and the absencereceptor (Egfr), a receptor tyrosine kinase (RTK), con-
of Sprouty causes excess branching (hence its name).trols many aspects of cell fate in animal growth and
Hacohen et al. (1998) cloned and sequenced sproutydevelopment. This has been well illustrated in Drosoph-
and proposed from its phenotype, sequence, nonauton-ila, where the Egfr controls cell proliferation, survival,
omy in mosaic animals, and its behavior in cell cultureand differentiation in a wide variety of tissues (Perrimon
that Sprouty was a secreted protein that inhibits Fgfrand Perkins, 1997; Schweitzer and Shilo, 1997; DomõÂn-
activation. Since the Egfr and Fgfr show no obviousguez et al., 1998). The principal signal transduction path-
sequence similarity in their extracellular domains, weway used by the Drosophila Egfr is the Ras1/MAP kinase
were surprised to find Sprouty in our screen, which waspathway (DõÂaz-Benjumea and Hafen, 1994). Because
focused specifically on regulators of the Egfr.many fate decisions are controlled by a single signaling
We describe here the function of Sprouty in regulatingpathway, the question arises of how the specificity of a
RTKs. Genetic analysis confirms that Sprouty is a potentcell's response is controlled. Part of the answer lies in
inhibitor of Egfr signaling in the eye, where it is importantthe state of the cell when it receives the Egfr/Ras1/MAP
for cell determination. Sprouty also regulates signalingkinase signal; at a specific point in development, cells
by Torso, another unrelated RTK, and apparently by theare poised to respond in a particular way (Freeman,
Sevenless RTK. Its ability to regulate a wide range of1996; GonzaÂ lez-Reyes and St. Johnston, 1998). It fol-
RTKs is explained by cell culture and biochemical analy-lows that normal development requires precise spatial
sis: Sprouty is an intracellular protein that interacts di-and temporal regulation of Egfr pathway activity.
rectly with several members of the Ras1/MAP kinaseSeveral mechanisms control signaling by the Dro-
pathway. We conclude that Sprouty is a novel inhibitorsophila Egfr. Among these are the regulated expression
of the Ras1/MAP kinase pathway involved in negativeand processing of ligands; the presence of a secreted
feedback control of signaling in multiple contexts.inhibitor, Argos; the transcriptional downregulation of
Egfr after prolonged signaling; and a number of regula-
tors of the Ras/MAP kinase signal transduction pathway Results
(for reviews, Wasserman and Freeman, 1997; Sternberg
Sprouty Inhibits Signaling by the Egfr
We used a genetic modifier screen to identify new com-* To whom correspondence should be addressed (e-mail: mf1@mrc-
ponents of Egfr signaling. A lethal complementationlmb.cam.ac.uk).
² These authors contributed equally to this work. group of seven alleles suppressed the rough eye caused
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Table 1. Further Genetic Interactions between sprouty and
Members of the Egfr Pathway
Genotype styS73/1 styS73/1 styS88/1
Eye Wing Eye
GMR-argos/1 22 N/A 22
sev-sspi/1 1 N/A 1
spiscp1/spiscp1 22 N/D 22
sev-tor4021Egfr 11 N/A 1
Egfrtop1/Egfrtop3C81 22 2 22
Egfrtop1/EgfrDf18A 22 2 22
GMR-Gal4/1; UAS-Egfr/1 1 11 1
sev-rho/1 11 N/A 11
sev-S/1 11 N/A 11
argoslD7/1 1 1 1
The effects of a 50% reduction in styS73 or styS88 on excess or reduced
signaling through Egfr are shown. The effects were scored in the
eye and, where applicable, also in the wing (the sevenless driver
does not express in the wing). ``11'', strong enhancement; ``1'',
weak enhancement; ``22'', strong suppression; ``2'', weak sup-
pression. N/A, not applicable. N/D, not determined.
Egfr signaling. We found that this complementation
group is allelic to sprouty; it also maps to 63D1-2 on
the third chromosome. All seven alleles fail to comple-
ment the pupal lethality of a sprouty null mutation (styD5)
(Hacohen et al., 1998) and exhibit the sprouty embryonic
tracheal phenotype (data not shown); finally, styD5 sup-
presses argos overexpression (data not shown).
Sprouty is an inhibitor of FGF receptor signaling and
was proposed to be an extracellular factor (Hacohen et
al., 1998). To exclude that the genetic interactions we
detected could be the result of an unknown function of
the Fgfr in the eye, we removed the two Drosophila Fgfrs
(encoded by the breathless and heartless genes) during
eye development. Mitotic clones in the eye that were
homozygous for amorphic alleles of either gene were
wild type (data not shown), demonstrating that the inter-
actions we see in the eye cannot be attributed to Sprouty
acting on the Fgfrs.
Further genetic tests provide evidence that Sprouty
interacts specifically with the Egfr pathway. First, halv-
ing the dose of sprouty strongly enhances the rough
eye caused by the misexpression of rhomboid (Figures
1C and 1D), a specific activator of Egfr signaling (Bier etFigure 1. sprouty Genetically Interacts with Egfr Mutations
al., 1990; Golembo et al., 1996). Second, halving sprouty(A) Overexpression of argos under the control of the GMR enhancer
causes a rough eye. suppresses the rough eye caused by underrecruitment
(B) GMR-argos is suppressed by heterozygosity for sproutyS73. of photoreceptors in a hypomorphic allele of spitz, the
(C and D) The rough eye caused by overexpressing the Egfr-activat- TGFa-like ligand of the Egfr. Third, halving sprouty sup-
ing protein Rhomboid under the sevenless promoter (C) is strongly
presses the phenotypes of Egfr hypomorphic mutationsenhanced (D) when heterozygous for sproutyS73.
both in the eye and the wing (Figures 1E±1H). Fourth,(E and F) Flies with the hypomorphic Egfr mutation Egfrtop1/Egfrtop3C81
flies heterozygous for both sprouty and argos havehave a rough eye (E), which is suppressed (F) when heterozygous
for sproutyS73. mildly rough eyes (Figure 1I), caused by a slight overre-
(G and H) A similar suppression of an Egfr hypomorphic phenotype cruitment of all types of cell, although heterozygosity
is seen in the wing: (G) Egfr hypomorphs (Egfrtop1/Egfrtop3C81) have a for either mutation alone causes no phenotype. Other
gap in the L4 vein (arrowhead), and the anterior crossvein is lost
genetic interactions between sprouty and the Egfr path-(arrowhead in [H]); (H) when heterozygous for sproutyS73, the missing
way are listed in Table 1. All point to the same conclu-veins are restored.
sion: Sprouty inhibits Egfr signaling.(I) Halving both sprouty and argos (sproutyS73/argoslD7) causes a
mildly rough eye, even though both genes are recessive.
Sprouty Regulates Cell Recruitment in the Eye
The Egfr is the principal trigger of cell recruitment in the
eye (Freeman, 1996), and, consistent with this, we foundby overexpressing Argos, the Egfr inhibitor (Figures 1A
and 1B). This suppression indicates that the gene de- Sprouty to be an important negative regulator of this
process. Ommatidia in sprouty2 mitotic clones have toofined by this complementation group is an inhibitor of
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the imaginal discs of these styS73/styS88 transheterozy-
gotes (Figure 2B). The earliest stages of ommatidial dif-
ferentiation look normal when eye imaginal discs are
stained with a ubiquitous neural marker, anti-Elav. Extra
recruitment is first apparent with the transformation of
some of the ªmystery cellsº to photoreceptors and be-
comes more pronounced at the stage when R7 photore-
ceptors are recruited. At this stage, many cells normally
destined to become cone cells instead adopt a neural
fate. No excess R8s (which are morphologically similar
to R7s in the adult eye) were seen in imaginal discs
stained with anti-Boss, an R8-specific antibody, con-
firming that the excess photoreceptors in the adult are
indeed R7s (Figure 2C).
As predicted for a suppressor of Egfr signaling, excess
recruitment in the eyes of sprouty mutants is not con-
fined to photoreceptors. sprouty2 pupal retinas also
have extra non±photoreceptor cellsÐthe cone and pig-
ment cells (Figure 2D). In wild-type eyes, there are four
cone cells per ommatidium, compared to an average of
4.86 (n 5 100) in sproutyS73 mutants, and two primary
pigment cells per ommatidium, compared to 2.26 (n 5
100) in sproutyS73 mutants. styS73/styS88 mutant adults also
have extra wing vein material (Figure 2E), another pheno-
type associated with excess Egfr activity.
Overexpression of sprouty Mimics Loss
of Egfr Signaling
Genetic evidence indicates that Sprouty is an inhibitor
of Egfr signaling and thus of cell recruitment. We further
tested this by overexpressing sprouty in the developing
Figure 2. sprouty Loss-of-Function Phenotypes eye and wing. As predicted, overexpression in the eye
(A) sproutyS73 mutant ommatidia in clones in adult eyes have excess substantially reduces the number of photoreceptors
photoreceptors; the arrowhead indicates a typical ommatidium with (Figures 3A and 3B); by examining the imaginal discs of
three R7-like cells.
these flies, it is clear that this is due to initial underre-(B) A third instar eye imaginal disc of genotype sproutyS73/sproutyS88,
cruitment (Figures 3C and 3D) at an early stage. Thestained with an antibody that recognizes the ubiquitous neural
extremely rough eye of sev-Gal4-driven UAS-Sproutymarker Elav. Excess cells are recruited as neurons: the arrowhead
indicates an example of a ªmystery cellº transformed into a neuron, (Figure 3E) is further explained by a reduction in the
and the arrow the more common transformation of a cone cell pre- number of cone and pigment cells (Figure 3F). In the
cursor into a neuron. In this and all other images of imaginal discs, wing, vein determination and imaginal disc proliferation
the morphogenetic furrow is toward the left, and the successive
are both dependent on the Egfr. Overexpressed Sproutyrecruitment is therefore seen from left to right.
causes a substantial loss of wing veins (Figure 3G) and(C) An imaginal disc of the same genotype as (B), stained with anti-
a reduction in wing size of 50% (n 5 3; due to a reducedElav (brown) and anti-Boss (black) to identify R8 cells. There is only
a single R8 cell in each ommatidium, confirming that the supernu- number of cells). Sprouty is therefore a potent inhibitor
merary cells with small rhabdomeres in adult ommatidia are R7s. of Egfr-mediated events in imaginal disc development.
(D) Pupal retina of genotype sproutyS73/sproutyS73, stained with co-
balt sulphide. Wild-type ommatidia have four cone cells and two
primary pigment cells; most of the mutant ommatidia have extra sprouty Expression Is Dependent on Egfr Signaling
cone cells (c) and many have extra primary pigment cells (1). We examined the expression of sprouty in the eye imagi-
(E) sproutyS73/sproutyS88 wings have extra vein material (arrowheads) nal disc by immunostaining the l(3)01943 enhancer trap
characteristic of Egfr hyperactivity.
line, which has the lacZ gene inserted at the sprouty
locus (Spradling et al., 1995). This line faithfully repre-
sents sprouty RNA expression pattern in the embryomany photoreceptors (Figure 2A): an average of 10.6
(n 5 30), compared to eight in wild-type ommatidia. (Hacohen et al., 1998). In eye imaginal discs, sprouty-
lacZ is detected only behind the morphogenetic furrow,There are some extra photoreceptors of the R1±R6
class, but most of the excess photoreceptors have small in the region where Egfr-mediated recruitment occurs
(Figures 4A and 4B). It appears successively in each ofrhabdomeres and are positioned centrally, characteris-
tic of the R7 or R8 class. Although most sprouty2 animals the newly recruited cells, both in photoreceptors and
cone cells, a pattern that strongly suggests that sproutydie as pupae, we found occasional adult survivors of
transheterozygotes between a strong and a medium- expression is dependent on Egfr signaling itself. This is
confirmed by loss of sprouty-lacZ staining in many cellsstrength allele (styS73/styS88). The overrecruitment pheno-
type in the adult eyes of these flies is indistinguishable when Egfr signaling is blocked (with a dominant-nega-
tive form of the receptor) and an increased number offrom the clones described above (data not shown).
To examine the origins of the excess cells, we studied cells expressing sprouty in the presence of an activated
Cell
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Figure 4. sprouty Expression and Autonomy
(A±D) sprouty expression is dependent on Egfr signaling. In these
panels the sprouty-lacZ enhancer trap (l(3)01943) is detected with
an anti-b-gal antibody. (A) sprouty-lacZ expression in the photore-
ceptors mirrors the sequential pattern of their Egfr-mediated recruit-
ment. (B) sprouty-lacZ is also expressed in the cone cells (arrow-
heads) as they are recruited in the posterior (i.e., older) part of the
disc. (C) Both recruitment and sprouty-lacZ expression are blocked
when a dominant-negative form of the receptor is expressed in
all cells (GMR-Gal4 3 UAS-DNEgfr). (D) Many extra cells express
Figure 3. Phenotype of sprouty Overexpression sprouty-lacZ when Egfr is constitutively activated in all cells behind
the morphogenetic furrow (GMR-Gal4 3 UAS-torDEgfr).(A) Section through a wild-type adult eye. Seven of the eight photore-
(E and F) sprouty acts cell autonomously to recruit R7 in a sevenlessceptors are visible in each ommatidium; they are identified by their
mutant. (E) sevd2 ommatidia have no R7 photoreceptors. (F) R7s doround, dark organelles, the rhabdomeres.
form when sprouty is removed in a mitotic clone in a sevd2 mutant(B) When UAS-sprouty is driven in the eye by sev-Gal4, there is a
eye. The only cell that needs to be mutant in these ommatidia is R7reduction in the number of photoreceptors.
itself, indicating an autonomous function of sprouty. The arrowhead(C and D) This loss of photoreceptors is caused by initial underre-
indicates a sevd2 ommatidium in which all photoreceptors exceptcruitment: (C) a wild-type eye imaginal disc stained with the neural
the R7 are sprouty1.marker, anti-Elav; increasing recruitment of neural cells is seen from
left to right. (D) Expression of UAS-sprouty under the control of
GMR-Gal4 (another eye-specific enhancer) causes recruitment to dependent upon, Egfr activation in the follicle cells of
occur normally at first, but it never proceeds beyond the three- or the egg. Similarly, sprouty expression was shown to befive-cell stage.
dependent on Fgfr signaling in the trachea (Hacohen(E) The adult eye of sev-Gal4 3 UAS-sprouty is extremely rough.
et al., 1998). Although the widespread dependence of(F) Much of this can be accounted for by the extreme reduction in
sprouty expression upon RTK signaling could be indi-the number of cone (c) and pigment cells seen in a cobalt sulphide
stained retina. rect, it has important developmental consequences, as
(G) When UAS-sprouty is overexpressed in the wing (under the it implies that Sprouty participates in negative feedback
control of MS1096-Gal4), there is a dramatic loss of veins and a control of signaling.
size reduction of the wing.
Sprouty Functions Cell Autonomously in R7
form of the receptor (Figures 4C and 4D). These results By examining mosaic ommatidia, it is possible to ask
in the eye are consistent with our observations (data whether a sprouty mutant cell itself adopts an inappro-
priate fate (a cell-autonomous function) or whether thenot shown) that sprouty expression also follows, and is
Sprouty Blocks Ras Signaling
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(Chou and Perrimon, 1996). No sprouty2 eggs are pro-Table 2. sprouty Interacts with the torso Receptor
duced under these conditions with two alleles (see Ex-
Most Posterior Embryonic Segment perimental Procedures). This implies that there is a re-
Maternal Genotype A6 A7 A8 WT quirement for sprouty in the germline and prevented us
from analyzing the embryonic phenotype of completetrk5 Ð 236 (98%) 5 (2%) 0
sprouty loss.trk5; sprouty/1 Ð 102 (53%) 75 (39%) 16 (8%)
torHM 10 (4.3%) 210 (91.3%) 3 (1.3%) 7 (3.1%)
torHM; sprouty/1 5 (3%) 139 (75%) 25 (13%) 17 (9%)
Sprouty Is an Intracellular Protein AssociatedData in each column refer to actual numbers (percentages in brack-
with the Plasma Membraneets) of embryos terminating in the A6, A7, or A8 abdominal segment,
Sprouty inhibits signaling by at least three different RTKsor wild type (i.e., containing all segments A1±A8 plus terminal struc-
tures). that have no extracellular similarity but share an intracel-
For trk5, df 5 2, x2 5 125, p ,, 0.001; for torHM, df 5 3, x2 5 34, lular signal transduction pathway. We have also shown
p ,, 0.001. that sprouty is cell autonomous for R7 photoreceptor
cell determination. The simplest explanation is that
Sprouty is an intracellular protein that acts downstream
of RTKs. To explore this possibility, we examined themutant cell instead influences the fate of neighboring
behavior of the protein in cell culture. When expressedcells (a nonautonomous function). We performed mo-
in Drosophila S2 cells, neither N- nor C-terminally taggedsaic analysis in the adult eye by generating sprouty2
Sprouty-HA (which is functional in transformed flies) wasclones in a sevenless mutant (sevd2) background. sevd2
detected in the extracellular medium (data not shown),mutants have no R7 cells, but R7s form in the sevd2;
even after the addition of heparin or in the presence ofstyS73 double mutant ommatidia (Figures 4E and 4F). This
sodium chlorate, which can detach secreted proteinsresult is consistent with previous work that shows that
from components of the extracellular matrix. Moreover,R7 can be determined in the absence of Sevenless by
Sprouty copurifies with the membrane fraction of S2excess Egfr signaling (Freeman, 1996). The double mu-
cells, even after alkaline washes, demonstrating that ittant clone allowed us to ask whether absence of Sprouty
is indeed tightly associated with the plasma membraneis sufficient to convert a cell into an R7. Hacohen et al.
(Figure 5C).(1998) found sprouty to behave nonautonomously in the
Immunostaining transfected S2 cells showed Sprouty-trachea. In contrast, we found that sprouty acts strictly
HA localized principally at the plasma membrane andcell autonomously in R7 cells. In sevd2 ommatidia mosaic
also at some discrete internal structures to which thefor sprouty, all R7s are sprouty2 (n 5 160). Ommatidia
Egfr also localizes; we take these to be membrane-sur-were found where the only sprouty2 cell is the R7, im-
rounded organelles. Sprouty-HA immunostaining didplying that absence of Sprouty in a cell can be sufficient
not, however, precisely colocalize with immunostainingto transform it into an R7, even when all its neighbors
against the external domain of the Egfr; instead, it ap-are sprouty1 (Figure 4F, arrowhead).
peared consistently more internal (Figure 5A). Crucially,
both N- and C-terminally tagged Sprouty could be im-
munostained only in the presence of detergent, whichSprouty Inhibits Signaling by the Torso RTK
Our results demonstrate that Sprouty inhibits the Egfr permeabilizes the lipid bilayer of the plasma membrane
(Figure 5A). In a control experiment, the extracellular,as well as the Fgfr. We next investigated whether it might
also regulate other RTKs such as Torso, an unrelated but not the intracellular, domain of the Egfr can be de-
tected in the absence of detergent (Figure 5B). We alsoRTK that triggers the development of terminal structures
in the developing embryo (Casanova and Struhl, 1989). found that Sprouty could not be labeled by a surface
biotinylation reaction that does modify other extracellu-We found that Sprouty does influence Torso signaling:
halving sprouty allows the development of terminal lar proteins (data not shown). Taken together, these
results indicate that Sprouty is tightly associated withstructures in embryos laid by mothers homozygous for
either a temperature-sensitive mutation of torso or for the intracellular face of the plasma membrane.
Our data contrast with the previous suggestion thata hypomorphic allele of trunk, a proposed Torso ligand
(Casanova et al., 1995) (see Table 2). This means that Sprouty is a secreted protein (Hacohen et al., 1998). In
support of our genetic and biochemical data, we find noSprouty inhibits signaling through at least three unre-
lated RTKs. Furthermore, the predominance of extra R7s evidence for a signal peptide sequence in Sprouty (ana-
lyzed with SignalP [Nielsen et al., 1997]). The followingin sprouty mutant eyes strongly suggests that it also
inhibits Sevenless signaling, although it is impossible to experiments confirmed our conclusion that Sprouty is
intracellular. Sprouty contains multiple potential N-linkedestablish this unambiguously by genetic means, as the
consequences of signaling through Sevenless and the glycosylation sites, and we reasoned that if Sprouty
were an extracellular protein, some of those sites couldEgfr are indistinguishable.
Although Sprouty regulates Torso, sprouty2 embryos be glycosylated in the secretory pathway. However, in
the presence of tunicamycin, an inhibitor of N-linkeddo not have a phenotype that indicates excess Torso
signaling, instead having only a relatively late tracheal glycosylation, we found no evidence for Sprouty glyco-
sylation (Figure 5D). We then tested whether the poten-phenotype. To test whether the true embryonic sprouty
null phenotype was being masked by a maternal contri- tial glycosylation sites can be glycosylated if Sprouty is
forced into the secretory pathway. The putative signalbution of Sprouty to the embryo, we generated germline
clones of sprouty using the FLP-DFS selection system peptide sequence proposed by Hacohen et al. (1998)
Cell
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Figure 5. Sprouty Is an Intracellular Protein Figure 6. Genetic Interactions Place Sprouty Downstream of the
Egfr(A) An S2 cell transiently expressing Egfr and C-terminally HA-
tagged Sprouty stained with antibodies against the HA tag (green) (A) Adult eye of genotype sev-torDEgfr/1.
and the extracellular domain of the Egfr (red). The two antigens (B) The phenotype caused by excess Egfr signaling is strongly en-
are not coincident: Sprouty-HA immunostaining appears internal to hanced by halving sprouty (sev-torDEgfr/1; sproutyS73/1).
immunostaining against the extracellular part of the receptor. (C) A stronger line of flies carrying sev-torDEgfr/1.
(B) When the same cells are stained in the absence of detergent (D) This phenotype is suppressed by coexpressing UAS-sprouty
(saponin, 0.1%), the extracellular domain of the Egfr is detected but under the control of the sevenless enhancer.
Sprouty-HA is not.
(C) Sprouty-HA protein colocalizes with a membrane fraction of S2
cells (pellet) even after washing the membranes at pH10 to release
1994]) (Figures 6A and 6B) but had no effect on theperipherally associated proteins.
constitutive Ras1 (sev-Ras1V12) or Raf (sev-torD-Raf) phe-(D) Prevention of N-linked glycosylation with tunicamycin (1) does
not alter the mobility of Sprouty-HA, whereas it does change the notypes. We also found that overexpression of sprouty
mobility of Sprouty-HA linked to a bona fide signal peptide. This was able to rescue the phenotype caused by expression
indicates that the chimeric protein is glycosylated. of the constitutive Egfr (Figures 6C and 6D). These inter-
actions indicate that Sprouty acts downstream of (or
parallel to) the Egfr, but upstream of Ras1 and Raf.
(and the presumed leader sequence N-terminal to this
domain) was substituted with the Argos signal peptide, Sprouty Binds to Members of the Ras Pathway
which is known to work on heterologous proteins We wanted to test whether Sprouty interacts physically
(Howes et al., 1998). The chimeric protein was sensitive with other proteins in the Ras pathway. Both full-length
to tunicamycin (Figure 5D), indicating that the potential Sprouty and a truncated Sprouty containing residues
sites in Sprouty are susceptible to glycosylation if the 1±369 (i.e., without the cys-rich domain and C-terminal
protein is preceded by a signal peptide. However, as residues) were fused to GST and assayed for their ability
we have shown that these sites are not normally glycosy- to bind in vitro translated members of the Ras pathway
lated, we conclude that Sprouty does not contain a func- (Figure 7A). We detected strong interactions between
tional signal peptide and hence does not normally enter Sprouty and Drk, an SH2-SH3 containing adaptor pro-
the secretory pathway. In another experiment (data not tein homologous to mammalian Grb2 (Olivier et al., 1993;
shown), we found that the cell surface localization of Simon et al., 1993), and between Sprouty and Gap1, a
Sprouty was not affected by brefeldin-A, a drug that Ras GTPase-activating protein (Gaul et al., 1992). No
disrupts the secretory pathway (and thus the localization interactions were seen between Sprouty and several
of proteins that pass through it including, in our controls, other proteins involved in the Ras pathway: Sos, Dos,
the Egfr). Our data therefore show unambiguously that Csw, Ras1, Raf, and Leo (14-3-3z). The interactions with
Sprouty is an intracellular protein. Drk and Gap1 did not require the presence of the
C-terminal cysteine-rich domain, the region of Sprouty
most conserved between flies and humans (Hacohen etSprouty Acts as an Inhibitor of Egfr Signaling
between the Receptor and Ras al., 1998). (Interestingly, the complete genome sequence
of C. elegans reveals no Sprouty homolog.)To determine where in the Ras signal transduction path-
way Sprouty acts, we asked whether altering its amount
could modify the phenotypes caused by expressing Sprouty Is Membrane Targeted
by the Cysteine-Rich Domainconstitutive forms of the Egfr, Ras1, and Raf in the eye.
Halving the dose of sprouty enhanced the phenotype Since the well-conserved cysteine-rich domain of Sprouty
is not required for binding to Drk or Gap1, we wonderedof constitutive Egfr (sev-torD-Egfr [Reichman-Fried et al.,
Sprouty Blocks Ras Signaling
661
Discussion
Hyperactivity of the Ras/MAP kinase pathway can be
dangerous. Since excessive or ectopic signaling can
lead to developmental defects and/or hyperproliferation
in many contexts, a number of negative regulators of
signaling have evolved to ensure its precise regulation.
Here we show that Sprouty is the most broadly acting
inhibitor of Ras/MAP kinase signaling in Drosophila to
date. It is required throughout development in multiple
tissues, and its loss causes strong phenotypes indica-
tive of Ras overactivity. The two other known inhibitors
of Ras/MAP kinase signaling, Argos and Gap1, are both
more limited in their function. Argos is a secreted protein
that specifically inhibits Egfr activation and therefore
has no effect on Ras/MAP kinase signaling by other
receptors (Schweitzer et al., 1995a). Gap1 is an intracel-
lular GTPase-activating protein that inactivates the GTP-
bound form of Ras (Gaul et al., 1992); like Sprouty, Gap1
can regulate signaling by diverse RTKs. However, unlike
Sprouty, Gap1 null mutants are viable and display only
eye and wing defects, implying that other Gaps must
be responsible for its function during Ras signaling in
earlier development.Figure 7. Molecular Mechanisms of Sprouty Function
Our discovery that Sprouty is an intracellular protein,(A) Sprouty binds to components of the Ras signaling pathway.
acting on the cytoplasmic signal transduction pathwayBinding assays in which in vitro translated proteins, labeled with
rather than the extracellular part of the receptor, ex-35S-methionine, are mixed with GST-Sprouty bound to sepharose
beads; bound proteins can be precipitated. For each of the three plains our observation that it acts on several different
proteins shown (Drk, Gap1, and Ras1), the three lanes are (from left RTKs. It also profoundly alters the type of model that
to right): 20% of the amount of the labeled protein used in each can account for its activity. Hacohen et al. (1998) pro-
assay (positive control, 1); the assay performed with GST alone
posed that Sprouty was secreted from a cell in response(negative control, 2); and the assay with GST-Sprouty (test). In the
to Fgfr signaling and was thus able to prevent neigh-case of Drk and Gap1, the assay shown is with the truncated form
boring cells from responding to ligand. In fact, Sproutyof Sprouty (lacking the C-terminal cysteine-rich domain; see Experi-
mental Procedures); with Ras1, which is negative, the full-length controls Ras/MAP kinase signaling directly by inhibiting
Sprouty is shown. signal transduction between the receptor and Ras. The
(B and C) The conserved cysteine-rich domain alone was tagged nonautonomous effects of sprouty in the trachea must
with the HA epitope (SproutyC) and was sufficient to localize Sprouty
therefore be indirectÐwhich can occur when, for exam-to the membrane of S2 cells (B), whereas upon deletion of this
ple, an intracellular protein regulates the expression ofdomain (SproutyDC) the protein was uniformly localized throughout
another secreted protein.the cell (C).
(D) SproutyDC is only found in the supernatant (sn) of fractionated We have shown that, as well as its role in Fgfr signal-
cells, whereas SproutyC is confined to the membrane pellet (p). ing, Sprouty regulates Torso, the Egfr, and probably
(E) Model of Sprouty action. By recruiting Gap1 and/or blocking the Sevenless. Nevertheless, zygotic loss of sprouty causes
ability of Drk to bind to its positive effectors, Sprouty prevents
a relatively minor and late embryonic phenotype of ex-the formation of functional signaling complexes associated with the
cess embryonic tracheal branching due to hyperactivecytoplasmic domain of receptor tyrosine kinases.
Fgfr signaling. The simplest explanation of why sprouty2
embryos do not show earlier and more dramatic pheno-
types (caused by excess RTK signaling by, for example,whether it might instead target the protein to the plasma
the Egfr and Torso) is that they are rescued by maternally
membrane. To test this, we expressed in S2 cells two
derived Sprouty. We were, however, unable to test this
truncated forms of Sprouty-HA. SproutyDC lacks the
prediction, as the requirement for Sprouty during oogen-
conserved cysteine-rich domain, whereas SproutyC esis stopped us from obtaining sprouty2 germline clones.
comprises exclusively the cysteine-rich domain. SproutyC Within the wing and eye imaginal discs, the phenotypes
is membrane associated (Figure 7B) and is indistinguish- of loss or gain of sprouty are consistent with our knowl-
able from the wild-type protein (see Figure 5A). In sharp edge of RTK and Ras signaling in development. Thus,
contrast, SproutyDC is distributed uniformly throughout in the wing, sprouty loss causes excess vein formation,
the cell (Figure 7C), with no specific localization to mem- and its overexpression leads to a striking loss of veins;
branes. Cell fractionation confirms this: SproutyDC is these phenotypes reflect Egfr misregulation (DõÂaz-Ben-
only found in the soluble fraction, whereas SproutyC is jumea and Garcia-Bellido, 1990; Sturtevant et al., 1993).
confined to the membrane pellet (Figure 7D). We con- In the eye, sprouty loss causes excess photoreceptors
clude that the 147-residue cysteine-rich domain in (especially R7s), cone cells, and pigment cells. sprouty
Sprouty, which corresponds to the most conserved re- overexpression in the eye abolishes photoreceptors,
gion in the published human ESTs, is responsible for cone cells, and pigment cells. These eye phenotypes are
the specific localization of Sprouty to the plasma mem- consistent with loss of Egfr and Sevenless regulation.
An intriguing aspect of Ras/MAP kinase inhibition bybrane.
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Sprouty is that the expression of sprouty is dependent the focus of a huge research effort because of its well-
on the pathway's activity, implying a negative feedback documented role in control of cell fate and proliferation
circuit. This was shown to be the case in the trachea (for recent reviews, Joneson and Bar-Sagi, 1997; Vojtek
(Hacohen et al., 1998), and we find the same in the eye and Der, 1998). Our results lead us to predict that a
and the follicle cells of the egg. Negative feedback loops mammalian Sprouty homolog will be a potent Ras path-
provide the potential for intricate control of signaling in way inhibitor. Interestingly, the domain of Sprouty that
development. Two classes of this type of control exist, has been most conserved between flies and humans is
depending on whether the feedback is autonomous, as the SproutyC membrane targeting domain. There are,
in the case of Sprouty, or nonautonomous, as with the however, small regions of similarity elsewhere in the
secreted inhibitor Argos (Freeman et al., 1992). The sig- protein, and these are obviously good candidates for
naling-dependent expression of argos controls spatial regions that mediate the Drk and Gap1 binding that we
regulation of the pathway (Freeman, 1997; Wasserman have identified and expect to be necessary for Sprouty
and Freeman, 1998), but the developmental logic of in- function. Finally, negative feedback control of Ras/MAP
tracellular negative feedback control of the Ras pathway kinase signaling can provide versatile developmental
remains to be determined. control (Freeman, 1997). The apparent existence of
The Ras pathway is activated, at least in part, by mammalian sprouty homologs will allow us to test
bringing together the signaling components into a com- whether this regulatory logic has been as well conserved
plex at the plasma membrane, in association with the as the signaling machinery itself.
tyrosine phosphorylated cytoplasmic tail of the receptor
(Aronheim et al., 1994; Leevers et al., 1994; Stokoe et Experimental Procedures
al., 1994). It is therefore interesting that Sprouty is also
Geneticstightly associated with the inner face of the plasma
sproutyS73 and sproutyS88 are members of a lethal complementationmembrane. It is targeted there by the cysteine-rich do-
class of seven alleles recovered as suppressors in an EMS screenmain that is the most conserved region between human
for dominant modifiers of GMR-argos in the eye. The eye suppres-and fly Sprouty. Several cysteine-rich membrane tar-
sion by sproutyS73 and the tracheal phenotype of homozygous mu-
geting domains have previously been described (e.g., tant embryos are indistinguishable from that of the null allele
Newton, 1995; van de Goor and Kelly, 1996); however, sproutyD5. In both aspects sproutyS88 is a weaker allele.
the lack of similarity between the SproutyC domain and The following alleles, described in Flybase, were used: argoslD7,
btlLG19, Egfrtop1, Egfrtop3C81, EgfrDf(18A), Gap1B2, GMR-Gal4 (Freeman,any of these suggests that SproutyC constitutes a novel
1996), htlAB42, sevd2, spiscp1, torHM, trk5, sev-Gal4, MS1096-Gal4 (Cap-type of membrane targeting sequence. Hacohen et al.
devila and Guerrero, 1994), sev-RasV12 (Fortini et al., 1992), sev-(1998) showed that two lethal mutations in Sprouty are
tor4021Egfr (Reichman-Fried et al., 1994), sev-tor4021Raf (Dickson etcaused by truncation of this SproutyC domain, sug-
al., 1992), UAS-Egfr, UASDN-Egfr (Freeman, 1996), sev-rho, sev-
gesting that membrane localization is essential for Star, sev-sspitz, UAS-tor4021Egfr (DomõÂnguez et al., 1998), w; P(w1)70C
Sprouty function. FRT80, w; P(w1)85D FRT80 (Xu and Rubin, 1993), w; P{w[1mC]5
How does Sprouty inhibit Ras activation? We specu- ovoD1-18}3L1 P{w[1mC]5ovoD1-18}3L2 P{w[1mW.hs]5.w[hs].}2A
(Chou and Perrimon, 1996), and l(3)01943, a nonmutagenic sproutylate that it may act through its direct binding to Drk and
enhancer trap (Spradling et al., 1995). Overlapping deficiencies cov-Gap1, two important components of the signal transduc-
ering the third chromosome were obtained from the Bloomingtontion pathway. Drk is an adaptor protein, homologous to
Stock Centre.Grb2, that recruits the Ras-activating protein, Sos, to
the active receptor complex (Lowenstein et al., 1992; Histology
Buday and Downward, 1993; Gale et al., 1993; Olivier Adult heads were embedded as described in Freeman et al. (1992).
et al., 1993; Simon et al., 1993). As described above, Cobalt sulphide staining of pupal retinas was performed as de-
scribed by Wolff and Ready (1991). Eye imaginal discs were stainedGap1 downregulates Ras1 activity. An attractive hypoth-
by standard protocols (e.g., Gaul et al., 1992). Embryos were stainedesis is that Sprouty recruits cytoplasmic Gap1 to the
according to standard protocols (Patel, 1994). Embryos of the cor-signaling complexes at the membrane. Such recruitment
rect genotype were identified by the absence of b-galactosidasecould then inactivate Ras (Figure 7E). Consistent with
staining (due to the presence of a lacZ-containing balancer chro-
this idea, sprouty2 and Gap12 clones have very similar mosome).
phenotypes in the eye (our data and Gaul et al., 1992). Primary antibodies used were as follows: a-Boss (mouse, 1:2000)
However, if Sprouty were acting exclusively by recruiting (Cagan et al., 1992); a-ELAV (rat, 1:100) (Robinow and White, 1988);
a-b-galactosidase (rabbit, 1:2000, Cappel); a-2A12, which recog-Gap1, the double mutant phenotype of sprouty2 Gap12
nizes an unknown antigen of the tracheal lumen (mouse monoclonal,should be the same as the single mutations, whereas we
1:5, Developmental Studies Hybridoma Bank) (Patel, 1994); a-Egfrfind that this is not the case (T. C. and M. F., unpublished
(mouse monoclonal, 1:10, J. D. Wasserman and M. F., unpublisheddata). It is also possible that by binding Drk, Sprouty
data); secondary antibodies came from Jackson ImmunoResearch.
prevents the recruitment of Sos or some other positive Wings were mounted according to Lawrence et al. (1985) except
regulator of signaling, thereby blocking the activation Euparal (Sigma) was used instead of GMM. Scanning electron micro-
of Ras1. Clearly, a more detailed study of Sprouty's graphs were prepared as described by Kimmel et al. (1990).
genetic and biochemical interactions is required before
Generation of Mitotic Cloneswe can fully understand the mechanism by which it
Mitotic recombination was induced using the FRT-FLP techniqueblocks Ras signaling.
(Xu and Rubin, 1993). To induce eye clones, first instar larvae of theSeveral human cDNAs related to sprouty have been
genotype w hsflp;P(w1)70C FRT80/sprouty FRT80 were heat-
reported (Hacohen et al., 1998), indicating that its se- shocked at 388C for 1 hr.
quence has been conserved over the 600 million years Eye clones of the two FGF receptors breathless and heartless
that separate Drosophila from mammals. Control of sig- were induced by X-ray. First instar larvae of the genotype w;
P(w1)70C/btl and w; P(w1)85D/htl were subjected to 1000 RAD.naling by the Ras pathway in mammalian cells has been
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Germline clones were induced by the FLP-DFS technique (Chou P Element Transformation
Both N-terminal and C-terminal tagged versions of Sprouty (de-and Perrimon, 1996). Third instar larvae of the genotype w
hsflp;ovoD3L FRT2A/sprouty FRT2A were heatshocked at 388C for scribed above) were subcloned into the pUAST vector (Brand and
Perrimon, 1993) and transformed into flies by standard tech-1 hr and again 24 hr later. Virgin F1 females were mated to balanced
sprouty males, and overnight embryo collections were made. When niques. The two transformant classes were phenotypically indistin-
guishable.either sproutyD5 or sproutyS73 was removed from the female germline,
we were unable to obtain any sprouty eggs.
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